, /PRNewswire/ – VBI Vaccines Inc. (“VBI” or the “Company“) today announced, that, in connection with its creditor protection proceedings under the Companies’ Creditors Arrangement Act (Canada) (the “CCAA“) and its previously announced sale and investment solicitation process, the Company completed the transactions (together, the “Transaction“) contemplated by that certain amended and restated acquisition agreement made effective as of October 24, 2024 (as amended from time to time, the “Acquisition Agreement“) with K2 VBI Equity Trust, LLC (the “Purchaser“), an affiliate of K2 HealthVentures LLC, one of the secured creditors of the Company and the lender under the debtor-in-possession financing implemented in connection with the CCAA proceedings. The Acquisition Agreement had been approved by the Ontario Superior Court of Justice (Commercial List) (the “Court“) on October 31, 2024.
Following completion of the Transaction, in accordance with the Acquisition Agreement and the Court order, all of the …